glp 1 drugs news Medicare will now help pay for some GLP-1 drugs. Here's what to know What to know about Medicare

These side effects can usually be reduced by initiating the medication at a low dose and titrating slowly

In a phase II study of the long-acting GLP-1RA efpeglenatide (4 mg once weekly, 6 mg once weekly, 6 mg once every 2 weeks, and 8 mg once every 2 weeks), patients with obesity and without diabetes had statistically significant reductions in body weight compared with placebo after 20 weeks of treatment (differences in least squares means were 6.3 to 7.2 kg

Appetite Reduction: They act on the brain to reduce appetite and increase feelings of fullness

Diabetes 70, 25452553 (2021)

Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop

doi: 10.1186/S12902-023-01500-5 99 LiaoMLiXZhangHZhouLShiLLiWet al